Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Tangent screens help detect visual field defects from vigabatrin.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The treatment combination is effective and generally safe for lung cancer.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Liver enzyme helps minoxidil work better for blood vessel relaxation.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Janus kinase inhibitors may help treat lichen planopilaris.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Feminizing hormone therapy increases kidney filtration rate.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

GD-23 reduces anxiety by relying on neurosteroid production.

Tirzepatide may improve hair loss by reducing insulin resistance.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

The new gel effectively treats MRSA-infected wounds for longer.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.